(Orange County Business Journal - 8/29/2010) Beckman Coulter Inc. has formed an executive team to address problems with a profitable heart disease test and expects to start selling it again by next summer.

...

We expect to see an increase in licensing deals and acquisitions as the big pharma players need to increase their pipelines," says Jim Prutow, director at management consulting firm PRTM.

Remember when the DxN was going to be the future of BC. Could it be pure B*** S*** to lure in a private capital buy out?

If you take away anything from the below about the DxN

....schedule for launch in 2010

....we don’t want to do anything that would slow down or delay the launch date on the DxN

All you haters, read it and weep:

MorphoSys AG and Xencor Sign License and Collaboration Agreement for Clinical Antibody Program; Xencor Will Receive $13 Million Upfront
6/28/2010

Washington, D.C., June 2, 2010 — The Securities and Exchange Commission today charged a former executive at a San Diego-based biotechnology company for making false statements to investors about her company's prenatal test for Down syndrome.

Sanofi to invest in Japan generic drug maker -Nikkei
Wed May 26, 2010 10:54pm * Sanofi to invest about 5 bln yen in Nichi-iko - Nikkei

Healthcare

* Sanofi to use deal to enter Japan generic market - Nikkei

* Japan generics market growing thanks to govt promotion

* Move will intensify competition, help market expand-analyst

"FreeSlate builds upon a tradition of enabling scientific R&D organizations to accelerate the pace of discovery while reducing costly, complex procedures that hinder efficiency," said John Senaldi, FreeSlate's chief executive officer.

AROUND 1,200 jobs are to be lost with the closure of one of Loughborough's biggest employers.

AstraZeneca today announced it is to shut its pharmaceutical plant in the town next year.

Staff were told this afternoon.

Loughborough MP Andy Reed said: "The word devastating is over used but I think that is the only way to describe this."

How will this stack up to Complete Gen and Pac Bio?

They just closed their microfluidic fab. Are Fluidigms days numbered?